After completing his specialist training in clinical oncology at the Edinburgh cancer centre, he did a clinical research fellowship at the Princess Margaret cancer centre and University of Toronto, further sub-specialising in genitourinary malignancies, advanced prostate radiotherapy and brachytherapy. During his fellowship, he was awarded the CARO-ACURA 2017 grant towards phase 2 study as principal investigator, for combining MRI-guided HDR brachytherapy with Stereotactic Body Radiotherapy (SABR) for Prostate Cancer.
He returned back from Toronto to take the role of consultant in clinical oncology at the Edinburgh cancer Centre in 2017. Here, he successfully led the case for implementing HDR-brachytherapy for prostate cancers. The first Scottish patient was treated in April 2021. He also does real-time planned LDR-brachytherapy for prostate cancers.
He is also a member of the SABR (or SBRT) group at the Edinburgh cancer centre for oligometastatic cancers. He does spine, bone and lymph node SBRT for all oligometastatic malignancies. He was awarded the RCR-Kay visiting fellowship 2019 learn new techniques in radiation oncology.As a lead for team 4 trials (Genitourinary cancers) at the ECC, he manages the trials team and is a principal investigator for a number of successfully running trials. He was appointed clinical lead for radiotherapy services in 2024.